Belite Bio, Inc
BLTE
$65.00
-$1.22-1.84%
| 12/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.20M | 2.09M | 2.22M | 1.36M | 1.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.46M | 6.96M | 10.96M | 6.87M | 6.88M |
| Operating Income | -11.46M | -6.96M | -10.96M | -6.87M | -6.88M |
| Income Before Tax | -10.10M | -6.99M | -10.93M | -6.81M | -6.89M |
| Income Tax Expenses | 0.00 | -1.00K | 1.00K | 3.00K | 6.00K |
| Earnings from Continuing Operations | -10.10M | -6.99M | -10.94M | -6.81M | -6.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.10M | -6.99M | -10.94M | -6.81M | -6.90M |
| EBIT | -11.46M | -6.96M | -10.96M | -6.87M | -6.88M |
| EBITDA | -11.42M | -6.92M | -10.95M | -6.86M | -6.87M |
| EPS Basic | -0.32 | -0.25 | -0.40 | -0.26 | -0.33 |
| Normalized Basic EPS | -0.20 | -0.15 | -- | -- | -- |
| EPS Diluted | -0.32 | -0.25 | -0.40 | -0.26 | -0.33 |
| Normalized Diluted EPS | -0.20 | -0.15 | -- | -- | -- |
| Average Basic Shares Outstanding | 31.46M | 28.32M | 27.32M | 25.79M | 20.95M |
| Average Diluted Shares Outstanding | 31.46M | 28.32M | 27.32M | 25.79M | 20.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
